ERCC1 and neoplasm: CTC characterization at primary diagnosis revealed that the presence of excision repair cross-complementing group 1 (ERCC1)- positive CTCs, an endonuclease associated with DNA repair, was an independent predictor for clinical platinum-resistance, whereas ERCC1-expression in corresponding primary tumor tissue predicted neither platinum-resistance nor prognosis [8].